Keros Therapeutics, Inc. (KROS)
NASDAQ
$10.61-0.28%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 198,861
- 52-week high
- —
- 52-week low
- —
- Open
- $10.75
- Day high
- $10.97
- Day low
- $10.51
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $244.06M | $87.01M | $2.30 |
| 2024 | $3.55M | -$187.35M | -$5.00 |
| 2023 | $151K | -$152.99M | -$5.20 |
| 2022 | $0 | -$104.68M | -$4.15 |
| 2021 | $20.1M | -$58.74M | -$2.52 |
About Keros Therapeutics, Inc.
A company overview for Keros Therapeutics, Inc. is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is Keros Therapeutics, Inc.'s stock price today?
- KROS is trading at $10.61 as of Jul 20, 2026.
- Does Keros Therapeutics, Inc. pay a dividend?
- Keros Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.